达安基因
(002030)
| 流通市值：104.56亿 | | | 总市值：104.56亿 |
| 流通股本：14.03亿 | | | 总股本：14.03亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 999,372,491.76 | 1,004,545,766.32 | 866,790,543.65 | 2,086,131,709.14 |
| 结算备付金 | 0 | 0 | - | - |
| 拆出资金 | 0 | 0 | - | - |
| 衍生金融资产 | 0 | 0 | - | - |
| 应收票据及应收账款 | 2,062,502,628.45 | 2,486,587,160.64 | 2,931,425,789.92 | 3,500,554,094.34 |
| 其中：应收票据 | 4,674,753.66 | 1,403,023.82 | 1,914,291.84 | 3,676,463.94 |
| 应收账款 | 2,057,827,874.79 | 2,485,184,136.82 | 2,929,511,498.08 | 3,496,877,630.4 |
| 应收款项融资 | 41,457,240.59 | 9,860,252.39 | 6,688,103.2 | 18,270,314.49 |
| 预付款项 | 42,989,134.13 | 104,691,262.79 | 123,155,052.99 | 128,275,343.17 |
| 应收保费 | 0 | 0 | - | - |
| 应收分保账款 | 0 | 0 | - | - |
| 应收分保合同准备金 | 0 | 0 | - | - |
| 其他应收款合计 | 50,002,754.43 | 54,127,317.1 | 101,027,093.92 | 64,882,867.92 |
| 其中:应收利息 | 0 | 0 | - | - |
| 应收股利 | 6,151,492.48 | 0 | 49,080,509.36 | - |
| 买入返售金融资产 | 0 | 0 | - | - |
| 存货 | 239,524,903.14 | 385,036,067.01 | 424,005,709.42 | 418,524,988.05 |
| 合同资产 | 0 | 0 | - | - |
| 一年内到期的非流动资产 | 106,350,181.14 | 72,192,178.62 | 79,722,950.8 | 120,298,511.44 |
| 其他流动资产 | 1,465,514,356.83 | 593,739,583.76 | 258,138,537.49 | 719,463,998.29 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,310,087,998.02 | 5,038,513,320.61 | 5,054,709,291.82 | 7,680,206,425.55 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 16,186,500 | 162,380.38 | 218,456.94 | 272,083.9 |
| 债权投资 | 0 | 0 | - | - |
| 其他债权投资 | 0 | 0 | - | - |
| 长期应收款 | 35,911,104.05 | 36,000,111 | 90,934,070.63 | 62,759,130.26 |
| 长期股权投资 | 846,537,388.1 | 890,459,645.64 | 910,436,862.51 | 994,244,376.84 |
| 其他权益工具投资 | 0 | 0 | - | - |
| 其他非流动金融资产 | 1,080,612,488.17 | 1,049,182,508.15 | 1,125,854,359.29 | 670,239,033.72 |
| 投资性房地产 | 27,613,561.53 | 21,127,263.93 | 21,251,746.11 | 21,376,228.34 |
| 固定资产 | 1,161,360,103.95 | 1,171,912,757.65 | 1,192,601,607.6 | 1,200,769,823.63 |
| 在建工程 | 727,353,133.34 | 757,511,935.91 | 761,967,099.13 | 631,583,904.63 |
| 生产性生物资产 | 0 | 0 | - | - |
| 油气资产 | 0 | 0 | - | - |
| 使用权资产 | 14,170,945.96 | 14,263,006.63 | 17,276,584.46 | 21,551,848.71 |
| 无形资产 | 279,697,175.93 | 278,237,133.51 | 265,610,645.09 | 216,010,953.5 |
| 开发支出 | 613,191,627.44 | 597,028,823.62 | 582,426,940.63 | 580,908,025.96 |
| 商誉 | 0 | 0 | - | - |
| 长期待摊费用 | 57,285,160.21 | 56,083,919.46 | 56,930,012.11 | 46,799,056.41 |
| 递延所得税资产 | 228,895,693.34 | 182,408,493.3 | 185,010,931.53 | 201,537,319.12 |
| 其他非流动资产 | 619,014,002.1 | 1,217,121,991.07 | 1,443,743,097.53 | 1,506,812,768.8 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,707,828,884.12 | 6,271,499,970.25 | 6,654,262,413.56 | 6,154,864,553.82 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 11,017,916,882.14 | 11,310,013,290.86 | 11,708,971,705.38 | 13,835,070,979.37 |
| 流动负债: | | | | |
| 短期借款 | 330,804,465.69 | 294,661,125.16 | 313,804,358.41 | 84,711,850.74 |
| 向中央银行借款 | 0 | 0 | - | - |
| 吸收存款及同业存放 | 0 | 0 | - | - |
| 拆入资金 | 0 | 0 | - | - |
| 交易性金融负债 | 0 | 0 | - | - |
| 衍生金融负债 | 0 | 0 | - | - |
| 应付票据及应付账款 | 425,437,095.31 | 383,510,484.11 | 570,340,840.99 | 610,577,957.81 |
| 其中：应付票据 | 0 | 0 | 98,921,091.51 | - |
| 应付账款 | 425,437,095.31 | 383,510,484.11 | 471,419,749.48 | 610,577,957.81 |
| 预收款项 | 0 | 0 | - | 16,887,740.84 |
| 合同负债 | 34,233,939.26 | 102,446,692.85 | 109,827,317.95 | 63,788,199.16 |
| 卖出回购金融资产款 | 0 | 0 | - | - |
| 应付手续费及佣金 | 0 | 0 | - | - |
| 应付职工薪酬 | 710,102,226.18 | 742,579,699.89 | 789,770,133.27 | 843,609,559.6 |
| 应交税费 | 53,168,864.24 | 50,548,967.66 | 50,624,184.92 | 200,266,805.52 |
| 其他应付款合计 | 107,287,924.55 | 84,288,226.08 | 133,630,005.24 | 154,654,811.63 |
| 其中:应付利息 | 0 | 0 | - | - |
| 应付股利 | 0 | 0 | - | - |
| 应付分保账款 | 0 | 0 | - | - |
| 保险合同准备金 | 0 | 0 | - | - |
| 代理买卖证券款 | 0 | 0 | - | - |
| 代理承销证券款 | 0 | 0 | - | - |
| 一年内到期的非流动负债 | 15,505,853.51 | 9,197,337.01 | 21,826,165.69 | 25,842,434.14 |
| 其他流动负债 | 1,827,193.46 | 2,943,891.1 | 13,585,047.88 | 2,176,235.84 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,721,088,205.33 | 1,712,730,466.99 | 2,045,962,097.48 | 2,045,069,638.41 |
| 非流动负债: | | | | |
| 长期借款 | 0 | 0 | - | - |
| 应付债券 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 租赁负债 | 21,814,317.7 | 32,341,116.88 | 26,894,581.81 | 23,657,753.42 |
| 长期应付款 | 5,295,000 | 5,920,000 | 6,720,000 | 5,858,883.85 |
| 长期应付职工薪酬 | 0 | 0 | - | - |
| 预计负债 | 113,918.22 | 0 | 3,572,800.7 | 20,055,240.69 |
| 递延收益 | 32,688,679.51 | 33,104,338.18 | 36,258,422.55 | 33,029,133.28 |
| 递延所得税负债 | 79,849,682.94 | 80,048,112.91 | 91,427,264.33 | 54,083,642.94 |
| 其他非流动负债 | 0 | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 139,761,598.37 | 151,413,567.97 | 164,873,069.39 | 136,684,654.18 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,860,849,803.7 | 1,864,144,034.96 | 2,210,835,166.87 | 2,181,754,292.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,403,446,032 | 1,403,446,032 | 1,403,446,032 | 1,403,446,032 |
| 其他权益工具 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 资本公积 | 651,544,521.92 | 659,454,714.1 | 659,454,714.1 | 719,989,645.48 |
| 减:库存股 | 0 | 0 | - | - |
| 其他综合收益 | -3,920,171.25 | -2,604,517.86 | -2,660,428.36 | -3,111,413.11 |
| 专项储备 | 0 | 0 | - | - |
| 盈余公积 | 1,271,543,871.4 | 1,250,174,329.85 | 1,250,174,329.85 | 1,250,174,329.85 |
| 一般风险准备 | 0 | 0 | - | - |
| 未分配利润 | 5,557,620,536.02 | 5,826,924,882.22 | 5,877,085,842.22 | 7,966,922,362.17 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 8,880,234,790.09 | 9,137,395,440.31 | 9,187,500,489.81 | 11,337,420,956.39 |
| 少数股东权益 | 276,832,288.35 | 308,473,815.59 | 310,636,048.7 | 315,895,730.39 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 9,157,067,078.44 | 9,445,869,255.9 | 9,498,136,538.51 | 11,653,316,686.78 |
| 负债和股东权益合计 | 11,017,916,882.14 | 11,310,013,290.86 | 11,708,971,705.38 | 13,835,070,979.37 |
| 公告日期 | 2024-03-30 | 2023-10-31 | 2023-08-31 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |